DNV GL Healthcare Focuses on Overcoming Antimicrobial Resistance in Nation’s Hospitals

NEXT STORY
electroCore Announces Comprehensive Redeployment and Cost Reduction Plan
PREV STORY
Aptose Announces Proposed Public Offering of Common Shares
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

TRACON Pharmaceuticals Announces Dosing of First Patient in ENVASARC Pivotal Trial

author_avatar
NASDAQ Market News

Immunocore Announces that U.S. Food and Drug Administration and European Medicines Agency accept Biologics License Application and Marketing Authorization Application for Tebentafusp in Metastatic Uveal Melanoma

author_avatar
NASDAQ Market News

COVID-19 Diagnostics Market Worth USD 8.04 Billion with Rise at 2.7% CAGR till 2027; Pharmaceutical Giants Such as Abbott and Roche to Pump More Funds for R&D Activities: Fortune Business Insights™

author_avatar
NASDAQ Market News